This talk will provide an update on the preclinical and clinical data of therapeutic drugs that include the AlbudAbTM half-life extension technology. It will cover lead discovery process/engineering and the selection of formats for improved biological, biophysical and pharmacokinetic properties, focussing on key in vivo and clinical data.
The European Laboratory Research & Innovation Group
Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Get the App
Get this event information on your mobile by going to the Apple or Google Store and search for 'myEventflo'
